60例流行性血热(下称EHF)随机分成两组,环胞苷组30例除综合治疗外,加用环胞苷200～300mg/d,连用3天。对照组30例,采取综合性治疔。结果低血压休克期十少尿期和少尿期越期率环胞苷组分别为52. 4%和28%,对照组分别为38. 6%和13%。环胞苷组病死率6. 7%,对照组为13. 3%。经显著性检验无差异。该药对EHF 的肯定疗效尚须进一步观察。 60 cases of epidemic hemorrhagic fever (hereinafter referred to as EHF) were randomly divided into two groups, 30 cases of cytidine group in addition to comprehensive treatment, add cytidine 200 ~ 300mg / d, once every 3 days. Control group of 30 patients, to take a comprehensive cure. 6% 和 13%. The results of hypotension shock ten oliguria and oliguria period cyclophosphamide group were 52.4% and 28%, respectively, the control group were 38.6% and 13%. Cyclidine group mortality of 6.7% in the control group was 13.3%. No significant difference after significant test. The drug for the positive effect of EHF still needs further observation.